3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Neoplasms
2
Vulvar Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Teratoma, Ovarian
1
Struma Ovarii
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Metabolic Syndrome
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Disease
1
Diabetes Mellitus
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Interventions
Thyroidectomy
5
Iodine-131
5
Surgical Procedures, Operative
3
selpercatinib
2
lenvatinib
2
anlotinib
2
Ultrasonography
2
Transurethral Resection of Prostate
2
Sorafenib
2
Molecular Diagnostic Techniques
2
Interviews as Topic
2
Focus Groups
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
dabrafenib
1
Triiodothyronine
1
Thyroxine
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Routinely Collected Health Data
1
Radiotherapy, Adjuvant
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nivolumab
1
Minimally Invasive Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Thyroid Neoplasms
×
DNA
×
Clear all
NCT04053114
2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn